# Secondary Prevention With Paroxetine vs. Placebo in Subthreshold Posttraumatic Stress Disorder (PTSD)

> **NCT00560612** · PHASE4 · COMPLETED · sponsor: **Durham VA Medical Center** · enrollment: 12 (actual)

## Conditions studied

- Stress Disorders, Post-Traumatic

## Interventions

- **DRUG:** Paroxetine
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT00560612
- **Lead sponsor:** Durham VA Medical Center
- **Sponsor class:** FED
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2006-01
- **Primary completion:** 2008-07
- **Final completion:** 2008-07
- **Target enrollment:** 12 (ACTUAL)
- **Last updated:** 2019-06-18


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00560612

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00560612, "Secondary Prevention With Paroxetine vs. Placebo in Subthreshold Posttraumatic Stress Disorder (PTSD)". Retrieved via AI Analytics 2026-06-15 from https://api.ai-analytics.org/clinical/NCT00560612. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*